The General Administration has issued ten measures to support the resumption of work and production, including a 50% reduction in inspection fees for special equipment under its jurisdiction.

By fully leveraging effective measures such as online processing, mobile‑app services, mail‑in applications, and appointment‑based handling, we will further streamline the registration process, reduce processing time and costs, and adopt a case‑by‑case approach for the registration of enterprises producing epidemic‑prevention supplies. In addition, we will promptly revise business scope standards to accommodate new industries and business models that have emerged during the pandemic.

For products of enterprises resuming or converting production that fall under the purview of production licensing or mandatory certification, expedited processing will be provided to shorten approval timelines. For enterprises that meet production requirements but are temporarily unable to submit the requisite documentation due to lengthy procedures, a notification-and-commitment system will be implemented: upon the enterprise’s commitment to supplement the relevant materials within a specified timeframe, the application will be concluded on the spot.

On the premise of ensuring food safety, streamline the licensing procedures for food production and operation, promote online processing, and expand the issuance of electronic certificates for food business licenses. For newly established enterprises applying for licenses and for those seeking license amendments that require on-site inspections, provincial market regulation authorities, based on the local food safety risk‑grading system, shall pilot a notification‑and‑commitment approach for low‑risk foods and, where eligible, implement a “license first, inspection later” regime.

Accreditation of inspection and testing institutions is now fully conducted online or by mail, with measures such as deferred assessments, commitment‑based notification, remote monitoring assessments, and expert document reviews being implemented.

To facilitate corporate mergers and acquisitions, the antitrust review of operator concentrations has been transitioned to an online filing system, enhancing the efficiency of reviewing simplified cases and ensuring the smooth execution of M&A transactions. The mechanisms for conducting antitrust reviews of operator concentrations have been streamlined, with strengthened guidance and support for corporate compliance with competition laws.

For manufacturing enterprises that convert to producing emergency supplies such as masks and protective suits, the production‑qualification approval process will be streamlined, with the product registration and production‑license inspection procedures merged. An expedited testing and inspection procedure will be initiated, and certain self‑inspection reports issued by these enterprises will be recognized. Once on-site verification confirms compliance with licensing requirements, product registration will be processed immediately, and a production license will be granted without delay. For enterprises that switch to manufacturing medical devices, an emergency approval mechanism will be implemented, and medical device registration certificates and production licenses will be issued in accordance with the law.

For registration applications of pharmaceuticals required for epidemic prevention and control, the review and approval process shall be expedited, while ensuring safety and efficacy. With respect to such medicines, provincial drug regulatory authorities shall guide enterprises in making appropriate production arrangements, fully mobilizing production capacity, and doing their utmost to ensure clinical supply. Special measures shall be implemented for the registration, manufacturing licensing, and inspection and testing of medical devices such as medical masks and protective suits, with approval procedures streamlined and consolidated.

Patent applications and trademark registrations related to the prevention and control of COVID‑19 shall be subject to priority examination upon request. Enterprises are encouraged to engage in intellectual property‑pledge financing, with a green channel established for IP‑pledge registration to facilitate swift access to funding and loan renewals, thereby alleviating financial constraints.

For business license registration items that have changed during the epidemic prevention and control period but cannot be promptly amended, the deadline for filing such changes shall be extended to within one month after the lifting of the epidemic.

For manufacturing enterprises whose industrial product production licenses have expired due to delays in renewal caused by the pandemic, license extensions may be granted; such extension applications shall be submitted after the pandemic has been lifted.

For food production and operation licenses that have expired, the validity period may be extended until the local epidemic is lifted.

Special equipment manufacturing units and inspection and testing institutions that are unable to complete license renewal on time due to the impact of the epidemic may apply for an extension of their licenses. Encourage qualified special equipment manufacturers to obtain license renewals without undergoing review by adopting a self-declaration commitment approach.

For inspection and testing institutions unable to apply for re‑inspection and license renewal on schedule due to the epidemic, the application may be deferred until after the epidemic has been lifted, with the certificate’s validity extended for three months following the lifting of the epidemic.

For enterprises resuming work and production, if patent, trademark, integrated circuit layout‑design, and other related procedures are delayed beyond the statutory time limits due to the impact of the epidemic, facilitative relief measures such as suspension or extension of deadlines and requests for restoration of rights shall be granted in accordance with the law.

Support the resumption of production by foreign‑trade export enterprises, accelerate the alignment of international and domestic standards, and promote the seamless integration of export products with both international and domestic standards. For products manufactured in accordance with international standards whose key technical indicators meet the mandatory safety requirements of national standards, domestic production and sales shall be permitted. Encourage social organizations to develop relevant group standards, thereby increasing the effective supply of standards needed for enterprises to resume work and production. Expedite the processing of applications from enterprises that produce masks meeting foreign standards for export but, despite having the capacity to manufacture masks compliant with domestic standards, have not yet obtained the requisite qualifications.

For enterprises engaged in the production and operation of epidemic‑prevention and control supplies that have already been listed on the List of Abnormal Operations, upon application by the enterprise, the removal process may be streamlined to expedite their delisting. For enterprises that have temporarily lost contact due to the impact of the epidemic, they may be temporarily exempted from being included on the List of Abnormal Operations.

Strengthen price oversight, rigorously investigate all unauthorized fee‑charging practices affecting businesses, and alleviate the burdens on enterprises as they resume work and production. Support companies in expanding production capacity, and crack down decisively on illegal activities such as price gouging in the manufacturing of masks and other epidemic‑prevention supplies, thereby safeguarding stable market prices for the machinery, equipment, and raw and auxiliary materials needed for producing these critical supplies.

A dedicated officer will handle type‑approval assessments, thereby shortening the testing period. For metrological standard instruments whose validity is about to expire, if the affiliated organization independently verifies that they continue to meet the relevant technical requirements, their validity may be appropriately extended.

Encourage standardization technical organizations and institutions to provide standardized advisory services and other technical support related to the resumption of business operations. Assist enterprises in promptly establishing practical epidemic‑prevention quality‑control procedures and standards, thereby enabling refined management that integrates epidemic prevention with the resumption of work. Launch a 24‑hour rapid response mechanism for item‑coding services.

Guide certification bodies to strengthen technical services for enterprises resuming work and production, establish integrated online channels for consultation, application processing, and evaluation, and streamline procedures by accepting certification applications online, deferring on-site audits and inspections, and prioritizing 3C certification arrangements.

During the epidemic prevention and control period, metrological verification institutions, product quality inspection and testing institutions, and special equipment inspection and testing institutions under the State Administration for Market Regulation reduced by 50% the fees for verification and calibration of measuring instruments, product quality inspection and testing services, and special equipment inspection services for enterprises resuming work and production. Furthermore, all such verification, calibration, and inspection and testing fees were waived for enterprises in Hubei Province. Standardization technical institutions under the State Administration for Market Regulation shall waive fees for international and domestic standard information consulting services, standard timeliness verification, and standard translation.

We will continue to deepen the “Ensure Prices, Ensure Quality, Ensure Supply” campaign, steadily expand its reach, and build a platform that fosters mutual understanding and trust between businesses and the public’s expectations. We will encourage and guide more enterprises to join this initiative, committing to accelerate the restoration of production capacity, uphold product quality, maintain price stability, and ensure market supply, thereby pooling concerted efforts to contain and control the epidemic.

Market regulation, drug administration, and intellectual property authorities at all levels must strengthen organizational leadership, assume greater responsibility, and, in close alignment with local conditions, further refine the ten policy measures, ensuring their thorough implementation and effective execution, so as to better support enterprises in resuming work and production and to decisively win the battle against the epidemic.